Klow
Imported raw material · Purity: ≥99.9%

Klow

  • ≥99%
  • In Stock
  • Selling Fast

Advanced peptide research pen formulated with Tirzepatide for metabolic and weight-management research applications. Designed for convenient subcutaneous research administration, this precision prefilled pen contains an investigational dual GIP and GLP-1 receptor agonist commonly studied for appetite regulation, glucose metabolism, energy balance, and body-weight research. Refrigerated storage recommended (2–8°C).

  • Specifications

Purity

≥99%

Dosage / Format

70mg Pen

Storage

Recommended 2-8°C

Origin

Switzerland Laboratory

  • Description

What KLOW Does

KLOW is an advanced peptide research formula featuring Tirzepatide, an investigational dual GIP and GLP-1 receptor agonist studied for its effects on metabolic regulation, appetite control, glucose metabolism, and body-weight management. By influencing pathways involved in hunger, satiety, and metabolic function, Tirzepatide has become a prominent subject of research in metabolic and obesity-related studies.

What May Be Observed

Research involving Tirzepatide commonly focuses on changes in appetite, food intake, body weight, glucose regulation, and broader metabolic markers. Studies have explored its potential to support improved metabolic control and reduced energy intake through its combined GIP and GLP-1 receptor activity. Research outcomes may vary depending on study design, dosage, and individual biological response.

  • Research Use Only. This product is intended exclusively for in vitro research and scientific study. It is not approved for human or veterinary use, and must not be used as a drug, food additive, or household chemical. For laboratory use only.